Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
July-2018 Volume 18 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2018 Volume 18 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Bidirectional modulation of insulin action by reactive oxygen species in 3T3‑L1 adipocytes

  • Authors:
    • Mingfeng Ma
    • Yingyao Quan
    • Yong Li
    • Xu He
    • Jing Xiao
    • Meixiao Zhan
    • Wei Zhao
    • Yongjie Xin
    • Ligong Lu
    • Liangping Luo
  • View Affiliations / Copyright

    Affiliations: Department of Cardiology, Zhuhai Hospital Affiliated with Jinan University (Zhuhai People's Hospital), Zhuhai, Guangdong 519000, P.R. China, Center of Intervention Radiology, Zhuhai Precision Medicine Center, Zhuhai People's Hospital, Zhuhai, Guangdong 519000, P.R. China, Department of Medical Imaging Center, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510630, P.R. China
    Copyright: © Ma et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 807-814
    |
    Published online on: May 14, 2018
       https://doi.org/10.3892/mmr.2018.9016
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Reactive oxygen species (ROS) serve an important role in glucose‑lipid metabolic regulation. In the present study, the results demonstrated that there was bidirectional regulation of insulin action in 3T3‑L1 adipocytes treated with ROS. Transient and acute ROS exposure improved insulin‑induced metabolic effects in 3T3‑L1 adipocytes. Hydrogen peroxide (H2O2), as a stable and diffusible ROS, diffused into adipocytes and altered intracellular redox homeostasis, resulting in oxidation and inactivation of phosphatase and tensin homologue deleted on chromosome 10 (PTEN). Inactivation of PTEN enhanced the activation of insulin‑induced protein kinase B (AKT), leading to increased glucose transporter 4 (GLUT4) redistribution and glucose uptake in 3T3‑L1 adipocytes. However, chronic ROS treatment induced insulin resistance in 3T3‑L1 adipocytes. It was also revealed that insulin‑induced AKT activation, GLUT4 translocation to cell membrane and glucose uptake were significantly inhibited in chronic ROS‑treated 3T3‑L1 adipocytes. Taken together, the present study provided further demonstration that transient ROS treatment improved insulin sensitivity; however, chronic ROS exposure induced insulin resistance in 3T3‑L1 adipocytes.

Introduction

Reactive oxygen species (ROS) have traditionally been viewed as an undesirable metabolic byproduct, which are principally generated by the mitochondrial respiratory chain and plasma membrane enzyme system (1). In obesity and type 2 diabetes mellitus, a high caloric diet causes a surplus of reducing equivalents, increasing electron transport in the mitochondrial respiratory chain and ROS generation (2–4). Other studies show that the endoplasmic reticulum (ER) is a potentially important source of ROS (2,5,6). The ER is an important site of protein folding and disulfide bond formation in eukaryotic organisms (7). The oxidation of cysteine residues and the release of electrons are involved in the formation of disulfide bonds, which results in the production of superoxide anions (O2•−) and other ROS (2,5). However, nutrient excess might overload the protein-folding ability of the ER and cause chronic ROS generation, resulting in insulin resistance, obesity and type 2 diabetes mellitus (2). Therefore, chronic ROS generation and oxidative stress can suppress the insulin response and contribute to the development of insulin resistance.

Although intercellular chronic oxidative stress induces insulin resistance in obesity and type 2 diabetes mellitus, ROS have an important role in insulin-regulated glucose and lipid metabolism (1,8,9). Previous studies reported that insulin activates nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in the plasma membrane, leading to hydrogen peroxide (H2O2) generation (10,11). The protein tyrosine phosphatase (PTP) family is oxidized and inactivated by ROS, which are dephosphorylases and catalyze the dephosphorylation of tyrosyl-phosphorylated proteins (12). Phosphatase and tensin homologue deleted on chromosome 10 (PTEN), one member of the PTP family, can dephosphorylate phosphatidylinositol-3-phosphate (PIP), phosphatidylinositol-3,4-bisphosphate (PIP2) and phosphatidylinositol-3,4,5-triphosphate (PIP3) in vitro, while it is likely that PIP3 is the most important substrate in vivo (13,14). Activation of insulin-induced phosphoinositide-3 kinase (PI3-K) catalyzes PIP3 generation to induce the phosphorylation and activation of protein kinase B (AKT) (15,16). Thus, PTEN and PI3-K have opposing effects on PIP3 content (17), and inactivation of PTEN enhances insulin-stimulated metabolic effects (18).

In insulin-signaling processes, insulin-induced insulin receptor (IR) phosphorylates insulin receptor substrate (IRS) proteins, which further phosphorylate the PI3-K regulatory subunit and activate the PI3-K catalytic subunit. PI3-K activation converts PIP2 to PIP3, which results in the activation of AKT (19). Subsequently, PI3-K/AKT signaling regulates glucose uptake, glycogen synthesis and lipid synthesis (15). In adipose cells and tissues, insulin-activated AKT signaling pathways promotes glucose transporter 4 (GLUT4) translocation to the cell membrane, increasing extracellular glucose uptake (20). However, GLUT4 defects or reduced expression in adipose cells and tissues can cause insulin resistance and metabolic syndrome in mouse models and patients (21,22). Thus, regulation of glucose uptake in fatty tissues has an important role in the development of whole-body insulin resistance and type 2 diabetes mellitus. In the present study, we find that transient H2O2 stimulation increases insulin sensitivity in 3T3-L1 adipocytes. H2O2 treatment oxidizes and inhibits PTEN, enhancing insulin-induced AKT phosphorylation, GLUT4 translocation and glucose uptake in 3T3-L1 adipocytes. However, chronic ROS exposure attenuates the insulin-stimulated AKT signaling pathway and causes insulin resistance in 3T3-L1 adipocytes. Our data indicate different effects of ROS on insulin-regulated signaling pathways in 3T3-L1 adipocytes.

Materials and methods

Materials

Dulbecco's modified Eagle's medium/Ham's nutrient mixture F12 (DMEM/F12) were purchased from Gibco Co. Ltd, Grand Island, NY, USA. Methylisobutylxanthine, dexamethasone and insulin were purchased from Tocris Bioscience (Bristol, UK). Oil Red O, [2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino)-2-deoxyglucose] (2-NBDG), N-acetylcysteine (NAC), N-ethylmaleimide (NEM) and glucose oxidase were purchased from Sigma-Aldrich (St. Louis, MO, USA). H2O2 was purchased from Guangzhou Chemical Reagent Factory, (Guangzhou, China). H2DCFDA and MitoTracker Red were purchased from Thermo Fisher Scientific, Inc. (Pittsburgh, PA, USA). Anti-PTEN (cat. no. 5384), anti-phospho-Thr308/309-AKT [AKT (T308/309P); cat. no. 13038)], anti-phospho-Ser473/474-AKT [AKT (S473/474P); cat. no. 9271)], anti-total-AKT (cat. no. 9272) and anti-GLUT4 (cat. no. 2213) were procured from Cell Signaling Technology, Inc. (Danvers, MA, USA). Anti-β-actin (sc-47778) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Goat Anti-Mouse IgG H&L (Alexa Fluor 680; ab175775), Goat Anti-Rabbit IgG H&L (Alexa Fluor 790; ab175781), Goat Anti-Mouse IgG H&L (Alexa Fluor 555; ab150114) and Goat Anti-Rabbit IgG H&L (Alexa Fluor 488; ab150077) were purchased from Abcam (Cambridge, MA, USA).

Cell culture and differentiation

The 3T3-L1 preadipocytes were obtained from the Chinese Academy of Science Cell Library (Shanghai, China). 3T3-L1 preadipocytes were cultured and differentiated into 3T3-L1 adipocytes as described previously (23). The preadipocytes were grown and maintained in DMEM/F12 containing 10% fetal bovine serum (FBS), 100 Us/ml penicillin and 100 µl/ml streptomycin in a 5% CO2, 37°C constant temperature/humidity incubator. When the cells had reached confluence, the cells were transferred to differential medium, DMEM/F12 containing 10% FBS, 0.5 mM methylisobutylxanthine, 0.25 µM dexamethasone and 1 µg/ml insulin, for 2 days, and then were incubated in DMEM/F12 containing 10% FBS and insulin (1 µg/ml) for 2 days. Subsequently, the cells were cultured in 10% FBS-DMEM/F12 medium. The 3T3-L1 adipocytes were experimented upon 8 days after differentiation.

Oil Red O staining

Oil Red O staining was performed as described previously (24). Briefly, the cells were washed with phosphate-buffered saline (PBS), and then fixed in 4% paraformaldehyde for 30 min. Subsequently, the cells were incubated with Oil Red O working solution for 10 min at room temperature, and rinsed under running tap water for 20 min. Finally, cells were sealed with nail polish and checked using a light microscope.

ROS treatment

For transient ROS treatment, 3T3-L1 adipocytes were incubated with serum-free medium supplemented with 100 µM H2O2 for 15 min. Then, the cells were used for further experiments. For chronic ROS treatment, the cells were exposed to fresh medium with 100 mU/ml glucose oxidase. Glucose oxidase catalyzed the conversion of glucose to glucuronic acid and H2O2, which generated about 40 µM H2O2 for 24 h (25). Then, the cells were used for further experiments.

Detection of intercellular ROS

3T3-L1 adipocytes were treated with 100 µM H2O2 or 10 nM insulin for 15 min and washed with PBS. Pretreatment with 200 µM NAC was performed for 30 min before H2O2 or insulin. Subsequently, the cells were incubated with 20 µM H2DCFDA for 15 min. Then, the cells were detected using the LSM510 confocal microscope (Zeiss, Jena, Germany), or were harvested and detected using flow cytometry sorting (FACS; BD Biosciences, Franklin Lakes, NJ, USA).

Glucose uptake and consumption assay

Glucose uptake was performed as described previously (26). In brief, 3T3-L1 adipocytes were starved in free-serum medium for 12 h, then treated with or without H2O2 or/and insulin for 30 min. Glucose uptake was measured using 2-NBDG. The cells were incubated with 10 mM 2-NBDG in PBS for 15 min at 37°C and extracted using a lysis buffer. 2-NBDG content was detected using a microplate fluorimeter (Infinite M200; Tecan, Hillsborough, NC, USA). Glucose consumption in the medium was performed using the Glucose Oxidase Method (GOM; Applygen Technologies Inc., Beijing, China). The cells were cultured in fresh serum-free medium for 3 h after the different treatments. The glucose content in the medium was determined using GOM.

Immunofluorescence

3T3L-L1 adipocytes were subjected to different stimulations, then fixed with 4% paraformaldehyde for 30 min, permeabilized with methanol for 15 min, and incubated with anti-AKT (S473/4P) (1:300) and anti-β-actin (1:300) at 4°C overnight. Then, the cells were incubated with Goat Anti-Mouse IgG H&L (Alexa Fluor 555; 1:300) for β-actin and Goat Anti-Rabbit IgG H&L (Alexa Fluor 488; 1:300) for AKT (S473/4P) for 3 h at room temperature. The cells were detected using confocal microscopy.

Immunoblot analysis

Immunoblot analysis was performed as described previously (27). In brief, 3T3-L1 adipocytes were lysed using RIPA buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.1% SDS, 1% NP-40, 5 mM EDTA, and 0.5% sodium deoxycholate) containing 1 mM PMSF. For the PTEN examination, cells were lysed with RIPA buffer containing 40 mM NEM and 1 mM PMSF. The total cell lysates were loaded onto SDS-PAGE gels and transferred to a PVDF membrane (Millipore, Billerica, MA, USA), which was incubated in the primary antibodies and the secondary antibodies. The results were detected with an ODYSSEY Infrared Imaging System (LI-COR Biosciences, Lincoln, NE, USA).

Cytoplasm and membrane fractions

Cytoplasm and membrane fractions were obtained as described previously (28). Briefly, 3T3-L1 adipocytes were homogenized in buffer 1 (10 mM Tris-HCl, 2 mM MgCl2, 0.2 M sucrose, 0.5 mM EDTA, pH 7.5) and centrifuged at 1,000 g for 10 min. The supernatant was centrifuged at 100,000 g for 40 min to obtain the cytoplasm fraction. The pellet was homogenized in buffer 2 (6 mM Tris-HCl, 1 mM EDTA, pH 8.0), centrifuged at 100,000 g 40 min, and then resuspended in buffer 3 (20 mM Tris-HCl, 1 mM EDTA, pH 7.5) and centrifuged at 100,000 g for 40 min to obtain the membrane fraction.

Statistical analysis

All experiments were performed three times independently. Results were presented as means ± standard error mean. Statistical analysis was performed using SPSS 13.0 software (SPSS, Inc., Chicago IL, USA) and significant differences were determined by Student's t-test or one-way analysis of variance with Tukey's post hoc test. P<0.05 was considered to indicate a statistically significant difference.

Results

H2O2 disrupts the intracellular redox balance in a manner similar to insulin stimulation

3T3-L1 preadipocytes are derived from mouse embryos and are a fibroblast cell type. The cells are differentiated into 3T3-L1 adipocytes, which exhibit characteristics of adipose cells, including the expression of lipid metabolic genes and the production of lipid droplets (29). Thus, this cell line is often used in lipid metabolic studies on adipose tissue. As shown in Fig. 1A, 3T3-L1 preadipocytes appeared to have a fusiform and flattened fibroblastic morphology, and converted into a ‘rounded-up’ morphology after differentiation. The number and size of the lipid droplets visualized by Oil Red O staining were gradually increased in a differentiating time-dependent manner (Fig. 1A). The 3T3-L1 adipocytes of 8-day differentiation were used in the subsequent experiments.

Figure 1.

H2O2 disrupts intracellular redox balance in the same manner as insulin stimulation. (A) Representative Oil Red O staining of 3T3-L1 cells was examined using a light microscope on the indicated differentiation days (scale bar, 50 µm). (B) Flow cytometric analysis for ROS level in 3T3-L1 adipocytes in the different treatments. (C) Quantitative analysis of DCF MFI as described for panel A. Data are presented as the mean ± standard error mean from three independent experiments. **P<0.01 vs. the control group. (D) Representative fluorescence images of intracellular ROS were obtained using confocal microscopy. ROS were stained with DCF (green), and mitochondrion were stained with MitoTraker Deeper Red (100 nM for 30 min; red). Scale bars, 20 µm. H2O2, hydrogen peroxide; ROS, reactive oxygen species; MFI, mean fluorescence intensity; DCF, 2′,7′-dichlorodihydrofluorescein; NAC, N-acetylcysteine.

The oxidation sensitive probe H2DCFDA is often used to examine intracellular ROS levels, and is cleaved by nonspecific esterases to transform into the dichlorodihydrofluorescein derivative H2DCF. H2DCF is oxidized and converts to fluorescent adduct DCF, and is trapped inside the cell (30,31). The results of the FACS analysis showed that insulin stimulation increased ROS generation in 3T3-L1 adipocytes, and H2O2 could disrupt the intracellular redox balance and increase intracellular ROS level (Fig. 1B and C). However, the ROS scavenger NAC inhibited H2O2-induced intracellular ROS accumulation in 3T3-L1 adipocytes (Fig. 1B and C). Furthermore, we detected DCF fluorescence using confocal microscope. The results showed that fluorescence intensity was significantly increased after either insulin stimulation or H2O2 treatment in 3T3-L1 adipocytes (Fig. 1D). These results demonstrated that H2O2, similar to insulin treatment, could increase intracellular ROS generation and change the redox balance in 3T3-L1 adipocytes.

Insulin sensitivity is improved in 3T3-L1 adipocytes after transient H2O2 treatment

PTEN can catalyze the dephosphorylation of PIP3, preventing insulin-induced PI3-K signaling to AKT and downstream of AKT (12,23). However, PTEN, as one of the important targets of ROS, is oxidized at cysteine residues and inactivated (27). Thus, we analyzed PTEN oxidation in 3T3-L1 adipocytes after transient H2O2 treatment. The cells were lysed in a buffer containing NEM to block free sulfhydryl groups, leading to increasing electrophoretic mobility in the oxidized form of PTEN. As shown in Fig. 2A, transient H2O2 treatment significantly increased PTEN oxidation in 3T3-L1 adipocytes. The PI3-K/AKT signaling axis regulates insulin-induced metabolic action, including glucose uptake, glycogen synthesis and lipid synthesis (32). Thus, AKT phosphorylation is often used to evaluate the activity of insulin signaling in insulin-response tissues or cells (33). AKT1/2 are activated via phosphorylation of Thr308/309 residues in the catalytic domain and Ser473/474 residues in the hydrophobic motif (34). We further detected AKT phosphorylation levels at Thr308/309 and Ser473/474 residues in 3T3-L1 adipocytes after transient H2O2 or/and insulin treatment. The result showed that the phosphorylation levels of AKT were significantly enhanced in insulin or/and transient H2O2-treated 3T3-L1 adipocytes, and that co-treatment with insulin and H2O2 promoted increased AKT phosphorylation compared with insulin stimulation (Fig. 2B). The statistical analysis was consistent with this result (Fig. 2C). Immunofluorescence analysis also revealed that transient H2O2 treatment enhanced the activation of insulin-induced AKT in 3T3-L1 adipocytes (Fig. 2D). These data suggested that transient H2O2 could enhance AKT activation through the oxidation and inactivation of PTEN, and improve insulin sensitivity in 3T3-L1 adipocytes.

Figure 2.

H2O2 treatment enhances insulin sensitivity in 3T3-L1 adipocytes. (A) Immunoblot analysis of PTEN oxidation in 3T3-L1 adipocytes stimulated with H2O2 for 5 min. (B) Immunoblot analysis of AKT phosphorylation in 3T3-L1 adipocytes under insulin and/or H2O2 treatments for 30 min. (C) Quantitative analysis of AKT phosphorylation protein level as presented in panel B. Data are presented as the mean ± standard error mean from three independent experiments. *P<0.05 and **P<0.01 vs. the control group; #P<0.05, as indicated. (D) Representative immunofluorescence images of AKT phosphorylation in 3T3-L1 adipocytes under the different treatments. Phosphorylation of AKT was stained with Anti-Rabbit IgG (green) and β-actin was stained with Anti-Mouse IgG (red). Scale bars, 20 µm. H2O2, hydrogen peroxide; PTEN, phosphatase and tensin homologue deleted on chromosome 10; AKT, protein kinase B; IgG, immunoglobulin G.

Transient H2O2 increases insulin-induced GLUT4 translocation and glucose uptake in 3T3-L1 adipocytes

We further analyzed the activation level of AKT-downstream signaling after different treatments in 3T3-L1 adipocytes. GLUT4, which is glucose transport protein that is highly expressed in adipose tissues, shifts from its intracellular location to the cell membrane via insulin-stimulated AKT signaling (35). The cytoplasm and membrane fractions assay showed that insulin increased GLUT4 translocation to the cell membrane, and co-treatment with both insulin and transient H2O2 also significantly enhanced GLUT4 redistribution in 3T3-L1 adipocytes (Fig. 3A). Consistent with this result, quantitative analysis revealed that the GLUT4 protein level at the cell surface was increased after insulin or/and transient H2O2 treatment, and the translocation effect with insulin and H2O2 co-treatment was more marked than with single insulin treatment (Fig. 3B). These results demonstrated that transient ROS increases the effect of insulin on the regulation of GLUT4 protein expression in 3T3-L1 adipocytes.

Figure 3.

H2O2 increases insulin-induced GLUT4 translocation and glucose uptake in 3T3-L1 adipocytes. (A) Immunoblot analysis of GLUT4 protein level in the cell membrane of 3T3-L1 adipocytes treated with insulin and/or H2O2. (B) Quantitative analysis of GLUT4 protein levels in the cell membrane as presented in panel A. (C) 2-NBDG uptake in 3T3-L1 adipocytes under the indicated treatments. (D) Glucose consumption by 3T3-L1 adipocytes in culture medium under the indicated treatments. Data are presented as the mean ± standard error mean from three independent experiments. *P<0.05 and **P<0.01 vs. the control group; #P<0.05, as indicated. H2O2, hydrogen peroxide; GLUT4, glucose transporter 4; 2-NBDG, 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino)-2-deoxyglucose.

We next examined changes in glucose uptake ability in 3T3-L1 adipocytes treated with insulin or/and transient H2O2. The level of intracellular 2-NBDG, a fluorescent glucose, was measured, and the results indicated that the 2-NBDG uptake level was significantly raised in 3T3-L1 adipocytes treated with insulin or/and transient H2O2 (Fig. 3C). The effect was best after co-stimulation with both insulin and H2O2 (Fig. 3C). Likewise, we examined the glucose consumption level in the culture medium. The results showed that the three different treatments led to increases in glucose utilization, and transient H2O2 markedly enhanced insulin-induced glucose consumption in the culture medium (Fig. 3D). These results demonstrated that transient ROS increased the insulin-stimulated glucose uptake level, suggesting that the insulin sensitivity of adipocytes is elevated by transient ROS.

Chronic H2O2 caused insulin resistance in 3T3-L1 adipocytes

The above data suggested that transient ROS treatment could enhance insulin-regulated metabolic effects (Figs. 2 and 3), thus we further explored metabolic alterations in adipose cells after chronic ROS exposure. As shown in Fig. 4A, incubation with glucose oxidase, which catalyzed the conversion of glucose to glucuronic acid and H2O2, did not change basic AKT phosphorylation levels; however, the phosphorylation levels of insulin-induced AKT in chronic ROS-treated adipocytes were significantly decreased. Densitometry analysis of phosphorylated AKT also produced the similar results (Fig. 4B). These data suggested that chronic ROS stimulation damaged 3T3-L1 adipocytes in response to insulin. The cytoplasm and membrane fractions assay showed the insulin-stimulated GLUT4 translocation to the cell surface was lower in chronic glucose oxidase-incubated adipocytes than in non-incubated cells (Fig. 4C and D). We further examined the changes in glucose absorption in 3T3-L1 adipocytes under chronic ROS treatment. Insulin promoted 2-NBDG uptake in 3T3-L1 adipocytes incubated with or without glucose oxidase; however, the capability of insulin-stimulated 2-NBDG absorption in chronic ROS-treated adipocytes was strikingly decreased (Fig. 4E). Consistent with this result, glucose consumption was also reduced in insulin-stimulated 3T3-L1 adipocytes incubated with glucose oxidase, compared with enzyme-free incubation (Fig. 4F). These results demonstrated that chronic ROS exposure impaired the insulin sensitivity of 3T3-L1 adipocytes.

Figure 4.

Chronic H2O2 causes insulin resistance in 3T3-L1 adipocytes. (A) Immunoblot analysis of AKT phosphorylation in glucose oxidase treated or untreated 3T3-L1 adipocytes under the indicated treatment. (B) Quantitative analysis of AKT phosphorylation protein level as presented in panel A. (C) Immunoblot analysis of GLUT4 protein level in the cell membrane of chronic ROS-treated or untreated 3T3-L1 adipocytes with the indicated treatments. (D) Quantitative analysis of GLUT4 protein level in cell membrane as presented in panel C. (E) 2-NBDG uptake in 3T3-L1 adipocytes under the indicated treatments. (F) Glucose consumption in culture medium by 3T3-L1 adipocytes of the different treatments. Data are presented as the mean ± standard error mean from three independent experiments. *P<0.05 and **P<0.01 vs. the control group; #P<0.05 and ##P<0.01, as indicated. H2O2, hydrogen peroxide; GLUT4, glucose transporter 4; AKT, protein kinase B; 2-NBDG, 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino)-2-deoxyglucose; ROS, reactive oxygen species.

Discussion

About 40 years ago, many studies reported that insulin can elicit ROS generation in skeletal muscles, adipose tissues, the liver and other target tissues and cells (36). Insulin activates NADPH oxidase, which is a plasma membrane enzyme, leading to H2O2 production (10,11,36). Our data also showed that insulin increased the intracellular ROS content in 3T3-L1 adipocytes. ROS oxidize and inactivate PTPs, such as PTEN and protein-tyrosine phosphatase-1b (PTP1b), which dephosphorylate insulin-induced phosphorylation to block insulin signaling (12,18,23). However, catalytic activation of PTPs depends on cysteine residues, which are highly susceptible to reversible oxidation and inactivation by ROS (37). A previous study further revealed that an increase in intracellular ROS content enhances insulin regulatory functions, but ROS scavengers attenuate these effects (18). Co-treatment with both H2O2 and insulin led to stronger metabolic regulation, including AKT activation, GLUT4 translocation and glucose uptake, compared with the single-insulin stimulation. Thus, transient and acute ROS treatment improves insulin sensitivity in adipose cells.

Although ROS have important roles in insulin-regulated metabolic pathways, chronic ROS or oxidative stress could cause activation of intracellular stress-sensitive pathways, resulting in insulin resistance and glucose-lipid metabolic diseases (38,39). ROS activate mitogen-activated protein kinases (MAPKs), such as c-Jun N-terminal kinase (JNK), through oxidation and inactivation of MAPK phosphatases (2). Many studies have also revealed that ROS activate apoptosis signal-regulating kinase 1 (ASK1) by oxidizing thioredoxin (TRX), which binds and inhibits ASK1 activation, leading to activation of the JNK signaling pathway (40,41). In addition, ROS also activate inhibitor of nuclear factor κ-B kinase subunit β (IKKβ) through Src and Abl tyrosine kinase signaling pathway (42). ROS-activated JNK and IKKβ phosphorylate IRS1 at Ser 302, 307 and 612 sites to block IRS1 binding to the IR and promote IRS1 degradation, resulting in attenuation of the delivery of insulin signaling (43). Therefore, chronic ROS treatment can induce and contribute to insulin resistance.

In conclusion, here we clarified that transient H2O2 enhances insulin sensitivity in 3T3-L1 adipocytes. Mechanistically, H2O2 treatment may enhance insulin-stimulated AKT activation through the oxidation and inactivation of PTEN compared with single insulin treatment, resulting in increased GLUT4 translocation and glucose uptake. Overall this study provides evidence to better understand the function of ROS in insulin signaling pathways in adipose cells.

Acknowledgements

Not applicable.

Funding

The present study was supported by the National Key Research and Development Program of China (grant no. 2017YFA0205200), National Natural Science Foundation of China (grant no. 81571785 and 81771957) and Natural Science Foundation of Guangdong Province, China (grant nos. 2016A030311055 and 2016A030313770).

Availability of data and materials

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

LLuo, LLu and MM conceived and designed the research. MM, YQ, YL, XH, JX, MZ, WZ and YX performed the experiments. MM processed and analyzed the experimental results. MM and YQ wrote the manuscript. All authors read and approved the manuscript.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Glossary

Abbreviations

Abbreviations:

ROS

reactive oxygen species

PTEN

phosphatase and tensin homologue deleted on chromosome 10

GLUT4

glucose transporter 4

ER

endoplasmic reticulum

PTPs

protein tyrosine phosphatases

PI3K

phosphoinositide-3 kinase

IR

insulin receptor

IRS

insulin receptor substrate

NAC

N-acetylcysteine

NEM

N-ethylmaleimide

FBS

fetal bovine serum

PTP1b

protein-tyrosine phosphatase-1b

MAPKs

mitogen-activated protein kinases

JNK

c-Jun N-terminal kinase

ASK1

apoptosis signal-regulating kinase 1

TRX

oxidizing thioredoxin

MFI

mean fluorescence intensity

MTR

MitoTraker Deeper Red

PBS

phosphate-buffered saline

NADPH

nicotinamide adenine dinucleotide phosphate

H2O2

hydrogen peroxide

IKKβ

nuclear factor κ-B kinase subunit β

References

1 

Turrens JF: Mitochondrial formation of reactive oxygen species. J Physiol. 552:335–344. 2003. View Article : Google Scholar : PubMed/NCBI

2 

Tiganis T: Reactive oxygen species and insulin resistance: The good, the bad and the ugly. Trends Pharmacol Sci. 32:82–89. 2011. View Article : Google Scholar : PubMed/NCBI

3 

Nishikawa T and Araki E: Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal. 9:343–353. 2007. View Article : Google Scholar : PubMed/NCBI

4 

Newsholme P, Haber EP, Hirabara SM, Rebelato EL, Procopio J, Morgan D, Oliveira-Emilio HC, Carpinelli AR and Curi R: Diabetes associated cell stress and dysfunction: Role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol. 583:9–24. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Riemer J, Bulleid N and Herrmann JM: Disulfide formation in the ER and mitochondria: Two solutions to a common process. Science. 324:1284–1287. 2009. View Article : Google Scholar : PubMed/NCBI

6 

Panzhinskiy E, Ren J and Nair S: Protein tyrosine phosphatase 1B and insulin resistance: role of endoplasmic reticulum stress/reactive oxygen species/nuclear factor kappa B axis. PLoS One. 8:e772282013. View Article : Google Scholar : PubMed/NCBI

7 

Freedman RB, Hirst TR and Tuite MF: Protein disulphide isomerase: Building bridges in protein folding. Trends Biochem Sci. 19:331–336. 1994. View Article : Google Scholar : PubMed/NCBI

8 

Figueira TR, Barros MH, Camargo AA, Castilho RF, Ferreira JC, Kowaltowski AJ, Sluse FE, Souza-Pinto NC and Vercesi AE: Mitochondria as a source of reactive oxygen and nitrogen species: From molecular mechanisms to human health. Antioxid Redox Sign. 18:2029–2074. 2013. View Article : Google Scholar

9 

Bedard K and Krause KH: The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev. 87:245–313. 2007. View Article : Google Scholar : PubMed/NCBI

10 

Mukherjee SP, Lane RH and Lynn WS: Endogenous hydrogen peroxide and peroxidative metabolism in adipocytes in response to insulin and sulfhydryl reagents. Biochem Pharmacol. 27:2589–2594. 1978. View Article : Google Scholar : PubMed/NCBI

11 

May JM and de Haën C: Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal fat cells. J Biol Chem. 254:2214–2220. 1979.PubMed/NCBI

12 

Seo JH, Ahn Y, Lee SR, Yeo Yeol C and Hur Chung K: The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway. Mol Biol Cell. 16:348–357. 2005. View Article : Google Scholar : PubMed/NCBI

13 

Gericke A, Munson M and Ross AH: Regulation of the PTEN phosphatase. Gene. 374:1–9. 2006. View Article : Google Scholar : PubMed/NCBI

14 

Ross AH and Gericke A: Phosphorylation keeps PTEN phosphatase closed for business. Proc Natl Acad Sci USA. 106:1297–1298. 2009. View Article : Google Scholar : PubMed/NCBI

15 

Taniguchi CM, Emanuelli B and Kahn CR: Critical nodes in signalling pathways: Insights into insulin action. Nat Rev Mol Cell Biol. 7:85–96. 2006. View Article : Google Scholar : PubMed/NCBI

16 

Cantley LC: The phosphoinositide 3-kinase pathway. Science. 296:1655–1657. 2002. View Article : Google Scholar : PubMed/NCBI

17 

Cheng CK, Fan QW and Weiss WA: PI3K signaling in glioma-animal models and therapeutic challenges. Brain pathol. 19:112–120. 2009. View Article : Google Scholar : PubMed/NCBI

18 

Loh K, Deng H, Fukushima A, Cai X, Boivin B, Galic S, Bruce C, Shields BJ, Skiba B, Ooms LM, et al: Reactive oxygen species enhance insulin sensitivity. Cell Metab. 10:260–272. 2009. View Article : Google Scholar : PubMed/NCBI

19 

Whelan SA, Dias WB, Thiruneelakantapillai L, Lane MD and Hart GW: Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes. J Biol Chem. 285:5204–5211. 2010. View Article : Google Scholar : PubMed/NCBI

20 

Cong LN, Chen H, Li Y, Zhou L, McGibbon MA, Taylor SI and Quon MJ: Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol Endocrinol. 11:1881–1890. 1997. View Article : Google Scholar : PubMed/NCBI

21 

Favaretto F, Milan G, Collin GB, Marshall JD, Stasi F, Maffei P, Vettor R and Naggert JK: GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1GT/GT, a mouse model for obesity and insulin resistance. PLoS One. 9:e1095402014. View Article : Google Scholar : PubMed/NCBI

22 

Chen YH, Heneidi S, Lee JM, Layman LC, Stepp DW, Gamboa GM, Chen BS, Chazenbalk G and Azziz R: miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance. Diabetes. 62:2278–2286. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Nakashima N, Sharma PM, Imamura T, Bookstein R and Olefsky JM: The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J Biol Chem. 275:12889–12895. 2000. View Article : Google Scholar : PubMed/NCBI

24 

Mehlem A, Hagberg CE, Muhl L, Eriksson U and Falkevall A: Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. Nat Protoc. 8:1149–1154. 2013. View Article : Google Scholar : PubMed/NCBI

25 

Potashnik R, Bloch-Damti A, Bashan N and Rudich A: IRS1 degradation and increased serine phosphorylation cannot predict the degree of metabolic insulin resistance induced by oxidative stress. Diabetologia. 46:639–648. 2003. View Article : Google Scholar : PubMed/NCBI

26 

Yang P, Zhao Y, Zhao L, Yuan J, Chen Y, Varghese Z, Moorhead JF, Chen Y and Ruan XZ: Paradoxical effect of rapamycin on inflammatory stress-induced insulin resistance in vitro and in vivo. Sci Rep. 5:149592015. View Article : Google Scholar : PubMed/NCBI

27 

Lee SR, Yang KS, Kwon J, Lee C, Jeong W and Rhee SG: Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem. 277:20336–20342. 2002. View Article : Google Scholar : PubMed/NCBI

28 

Jiang X, Huang L and Xing D: Photoactivation of Dok1/ERK/PPARγ signaling axis inhibits excessive lipolysis in insulin-resistant adipocytes. Cell Signal. 27:1265–1275. 2015. View Article : Google Scholar : PubMed/NCBI

29 

Bernlohr DA, Bolanowski MA, Kelly TJ Jr and Lane MD: Evidence for an increase in transcription of specific mRNAs during differentiation of 3T3-L1 preadipocytes. J Biol Chem. 260:5563–5567. 1985.PubMed/NCBI

30 

Turpin SM, Nicholls HT, Willmes DM, Mourier A, Brodesser S, Wunderlich CM, Mauer J, Xu E, Hammerschmidt P, Brönneke HS, et al: Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metab. 20:678–686. 2014. View Article : Google Scholar : PubMed/NCBI

31 

Quan YY, Qin GQ, Huang H, Liu YH, Wang XP and Chen TS: Dominant roles of Fenton reaction in sodium nitroprusside-induced chondrocyte apoptosis. Free Radic Biol Med. 94:135–144. 2016. View Article : Google Scholar : PubMed/NCBI

32 

Whiteman EL, Cho H and Birnbaum MJ: Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab. 13:444–451. 2002. View Article : Google Scholar : PubMed/NCBI

33 

Gonzalez E, Flier E, Molle D, Accili D and McGraw TE: Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor. Proc Natl Acad Sci USA. 108:10162–10167. 2011. View Article : Google Scholar : PubMed/NCBI

34 

Koseoglu S, Lu Z, Kumar C, Kirschmeier P and Zou J: AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines. Cancer Biol Ther. 6:755–762. 2007. View Article : Google Scholar : PubMed/NCBI

35 

Bryant NJ, Govers R and James DE: Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol. 3:267–277. 2002. View Article : Google Scholar : PubMed/NCBI

36 

Goldstein BJ, Mahadev K, Wu X, Zhu L and Motoshima H: Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxid Redox Signal. 7:1021–1031. 2005. View Article : Google Scholar : PubMed/NCBI

37 

Tonks NK: Protein tyrosine phosphatases: From genes, to function, to disease. Nat Rev Mol Cell Biol. 7:833–846. 2006. View Article : Google Scholar : PubMed/NCBI

38 

Bloch-Damti A and Bashan N: Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxid Redox Signal. 7:1553–1567. 2005. View Article : Google Scholar : PubMed/NCBI

39 

Ding H, Heng B, He W, Shi L, Lai C, Xiao L, Ren H, Mo S and Su Z: Chronic reactive oxygen species exposure inhibits glucose uptake and causes insulin resistance in C2C12 myotubes. Biochem Biophys Res Commun. 478:798–803. 2016. View Article : Google Scholar : PubMed/NCBI

40 

Matsukawa J, Matsuzawa A, Takeda K and Ichijo H: The ASK1-MAP kinase cascades in mammalian stress response. J Biochem. 136:261–265. 2004. View Article : Google Scholar : PubMed/NCBI

41 

Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T and Ichijo H: ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2:222–228. 2001. View Article : Google Scholar : PubMed/NCBI

42 

Storz P and Toker A: Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. EMBO J. 22:109–120. 2003. View Article : Google Scholar : PubMed/NCBI

43 

Gual P, Le Marchand-Brustel Y and Tanti JF: Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie. 87:99–109. 2005. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ma M, Quan Y, Li Y, He X, Xiao J, Zhan M, Zhao W, Xin Y, Lu L, Luo L, Luo L, et al: Bidirectional modulation of insulin action by reactive oxygen species in 3T3‑L1 adipocytes. Mol Med Rep 18: 807-814, 2018.
APA
Ma, M., Quan, Y., Li, Y., He, X., Xiao, J., Zhan, M. ... Luo, L. (2018). Bidirectional modulation of insulin action by reactive oxygen species in 3T3‑L1 adipocytes. Molecular Medicine Reports, 18, 807-814. https://doi.org/10.3892/mmr.2018.9016
MLA
Ma, M., Quan, Y., Li, Y., He, X., Xiao, J., Zhan, M., Zhao, W., Xin, Y., Lu, L., Luo, L."Bidirectional modulation of insulin action by reactive oxygen species in 3T3‑L1 adipocytes". Molecular Medicine Reports 18.1 (2018): 807-814.
Chicago
Ma, M., Quan, Y., Li, Y., He, X., Xiao, J., Zhan, M., Zhao, W., Xin, Y., Lu, L., Luo, L."Bidirectional modulation of insulin action by reactive oxygen species in 3T3‑L1 adipocytes". Molecular Medicine Reports 18, no. 1 (2018): 807-814. https://doi.org/10.3892/mmr.2018.9016
Copy and paste a formatted citation
x
Spandidos Publications style
Ma M, Quan Y, Li Y, He X, Xiao J, Zhan M, Zhao W, Xin Y, Lu L, Luo L, Luo L, et al: Bidirectional modulation of insulin action by reactive oxygen species in 3T3‑L1 adipocytes. Mol Med Rep 18: 807-814, 2018.
APA
Ma, M., Quan, Y., Li, Y., He, X., Xiao, J., Zhan, M. ... Luo, L. (2018). Bidirectional modulation of insulin action by reactive oxygen species in 3T3‑L1 adipocytes. Molecular Medicine Reports, 18, 807-814. https://doi.org/10.3892/mmr.2018.9016
MLA
Ma, M., Quan, Y., Li, Y., He, X., Xiao, J., Zhan, M., Zhao, W., Xin, Y., Lu, L., Luo, L."Bidirectional modulation of insulin action by reactive oxygen species in 3T3‑L1 adipocytes". Molecular Medicine Reports 18.1 (2018): 807-814.
Chicago
Ma, M., Quan, Y., Li, Y., He, X., Xiao, J., Zhan, M., Zhao, W., Xin, Y., Lu, L., Luo, L."Bidirectional modulation of insulin action by reactive oxygen species in 3T3‑L1 adipocytes". Molecular Medicine Reports 18, no. 1 (2018): 807-814. https://doi.org/10.3892/mmr.2018.9016
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team